Review Articles

Role of the tumor microenvironment in mature B-cell lymphoid malignancies

Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;Department of Haematology, Pathwest Laboratory Medicine WA and Sir Charles Gairdner Hospital, Perth, Western Australia;University of Western Australia, Perth, Canada
British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada
Department of Haemato-Oncology, Barts Cancer Institute, London, UK
Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Università Vita-Salute San Raffaele, Division of Experimental Oncology, IRCCS Istituto Scientifico San Raffaele, Milan, Italy;Department of Onco-Hematology, Ospedale San Raffaele, Milan, Italy
Children’s Research Institute, Washington, DC, USA
Division of Hematology, Mayo Clinic, Rochester, MN, USA
Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, MD, USA
University of California, Irvine, CA, USA
St. James’ Hospital, Dublin, Ireland
Cancer Therapeutic Evaluation Program, National Cancer Institute, Bethesda, MD, USA
University of Heidelberg, Germany
Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, MD, USA
Vol. 101 No. 5 (2016): May, 2016 https://doi.org/10.3324/haematol.2015.139493